Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Ma

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Molecular Therapy. Nucleic Acids|May 10, 2019
Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung AdenocarcinomaRui Chen, Wenjia Xia, Siwei Wang, et al.
Nature Cancer|March 26, 2024
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancersMaishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Ethnic differences and functional analysis of MET mutations in lung cancerSoundararajan Krishnaswamy, Rajani Kanteti, Jonathan S Duke-Cohan, et al.
The Oncologist|July 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumorsDan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, et al.
Cancer Research|July 4, 2020
Y Chromosome LncRNA Are Involved in Radiation Response of Male Non-Small Cell Lung Cancer CellsTayvia Brownmiller, Jamie A Juric, Abby D Ivey, et al.
JCO Precision Oncology|February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, et al.
The Oncologist|September 5, 2024
Proceedings of the 1st biannual bridging the gaps in lung cancer conferenceNarjust Florez, Sandip P Patel, Heather Wakelee, et al.
Cell Genomics|February 13, 2023
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilitiesRoberta Esposito, Taisia Polidori, Dominik F Meise, et al.
JCO Precision Oncology|December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) FusionsTejas Patil, Jessica J Lin, Parneet K Cheema, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Molecular Therapy. Nucleic Acids|May 10, 2019
Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung AdenocarcinomaRui Chen, Wenjia Xia, Siwei Wang, et al.
Nature Cancer|March 26, 2024
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancersMaishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Ethnic differences and functional analysis of MET mutations in lung cancerSoundararajan Krishnaswamy, Rajani Kanteti, Jonathan S Duke-Cohan, et al.
The Oncologist|July 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumorsDan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, et al.
Cancer Research|July 4, 2020
Y Chromosome LncRNA Are Involved in Radiation Response of Male Non-Small Cell Lung Cancer CellsTayvia Brownmiller, Jamie A Juric, Abby D Ivey, et al.
JCO Precision Oncology|February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, et al.
The Oncologist|September 5, 2024
Proceedings of the 1st biannual bridging the gaps in lung cancer conferenceNarjust Florez, Sandip P Patel, Heather Wakelee, et al.
Cell Genomics|February 13, 2023
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilitiesRoberta Esposito, Taisia Polidori, Dominik F Meise, et al.
JCO Precision Oncology|December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) FusionsTejas Patil, Jessica J Lin, Parneet K Cheema, et al.
Pageof 9